Fuzeon (enfuvirtide) Lyophilized Powder for Injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
December 2015
ADVERSE REACTIONS
Post Marketing Experience
Skin and Subcutaneous Tissue Disorders
Cutaneous amyloidosis at... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - December 1, 2015 Category: Drugs & Pharmacology Source Type: alerts